Skip to main content

Advertisement

Sports Medicine - Open
Sports Medicine - Open Cover Image
Download PDF

Influence of the MCT1 rs1049434 on Indirect Muscle Disorders/Injuries in Elite Football Players

Sports Medicine - Open volume 1, Article number: 33 (2015) Cite this article

Abstract

Background

The aim of this study was to investigate the association between MCT1 rs1049434 polymorphism and indirect muscle injuries in elite football players. One hundred and seventy-three male elite Italian football players (age = 19.2 ± 5.3 years) were recruited from a first-league football club participating at the Official National Italian Football Championship (Serie A, Primavera, Allievi, Giovanissimi). The cohort was genotyped for the MCT1 rs1049434 polymorphism, and muscle injuries data were collected during the period of 2009–2014 (five football seasons).

Methods

Genomic DNA was extracted using a buccal swab, and genotyping was performed using PCR method. Structural-mechanical injuries and functional muscle disorder were included in the acute indirect muscle injury group.

Results

Participants with the MCT1 AA (AA = 1.57 ± 3.07, n = 69) genotype exhibit significantly higher injury incidents compared to participants with the TT genotype (TT = 0.09 ± 0.25, n = 22, P = 0.04).

Conclusions

The MCT1 rs1049434 polymorphism is associated with the incidence of muscle injuries in elite football players. We anticipate that the knowledge of athletes’ genetic predisposition to sports-related injuries might aid in individualizing training programs.

Key Points

  • MCT1 rs1049434 TT genotype could influence the incidence of muscle injuries in elite football players.

  • This study emphasizes a possible future direction in considering genes that encode for monocarboxylate transporters within musculoskeletal soft tissues when examining the individual predisposition of football players to develop muscle injuries.

  • Additional research and replication studies are needed to support our data and to fully understand the relationship between predisposition to muscle injuries in football and the MCT1 rs1049434.

Background

Lactate is the end product of anaerobic glycolysis and is highly accumulated during high-intensity exercise. Lactate transport across the plasma membrane is mainly mediated by proton-linked monocarboxylate transporters (MCT1 and MCT4) [1–3] that play a relevant role in the intracellular pH homeostasis [4]. In fact, the rapid transport of lactic acid across the plasma membrane is fundamentally important for the metabolism of almost all cells, including skeletal muscle.

In 1992, Garcia et al. [5] cloned the first monocarboxylate transporter, MCT1, from Chinese hamster ovary cells and showed that it is expressed, among other tissues, in erythrocytes, skeletal muscle, and heart. Intercellular MCT1 is particularly important in skeletal muscle, where glycolytic fast twitch muscle fibers produce lactate, which is transported out of the cell through the monocarboxylate transporter (MCT). Lactate is then taken up and oxidized by the oxidative slow twitch muscle fibers, which express MCT1 [6]. Kinetic analysis of MCT1 has suggested that it translocates a proton (H+) and a monocarboxylate across the plasma membrane by an ordered mechanism in which H+ binding precedes monocarboxylate binding and, after translocation across the plasma membrane, the substrates are sequentially released in reverse order [4, 7]. However, it is important to note that the direction of flux is decided by the combined electrochemical gradients of lactate and proton [3].

SLC16A1 is the gene for human MCT1 and it is located on chromosome 1, in position 1p13.2-p12. Defects in SLC16A1 are the cause of symptomatic deficiency in lactate transport, also known as erythrocyte lactate transporter defect. Symptoms and signs of muscle injury on exercise and heat exposure and subnormal erythrocyte lactate transport have been related with the presence of two common single nucleotide polymorphisms (SNPs) in the SLC16A1 gene [8]. In particular, the A > T SNP located in protein coding region (coding base 1470), converting #490 Glutamic amino acid to Aspartic amino acid was associated with a reduction of 35–40 % in the erythrocytes lactate transport rate in two patients carrying the T allele [8].

A recent study showed a higher lactate blood accumulation slope in capillary (more arterialized) blood in T allele carriers than in non-carriers during high intensity (80 %, 15 repetition maximum (15RM)) circuit weight training) [9]. The same research group has recently found a higher venous blood lactate levels in AA genotype carriers compared to carriers of the AT and TT genotypes [10].

Lactate transporter defects in skeletal muscle might provide an explanation for some cases of easy fatigue and muscle cramping upon exercise due to delayed removal of the protons accumulated during (partially) anaerobic work [8]. Muscle fatigue has been shown to predispose to injury [11].

Muscle injury is one of the major disorders that football players are facing. It has been reported that muscle injuries account for 20 to 37 % of all time loss injuries at men’s professional level and 18 to 23 % at men’s amateur level [12, 13]. Muscle injuries are generally classified into two groups; indirect muscle injuries (can also refer as “non-contact” and are caused by internal forces) and direct muscle injuries (caused by external forces). Contusion and laceration are the most common direct muscle injuries. The severity of the direct injury depends on the contact force, the contraction state of the affected muscle at the moment of injury and other factors. However, the functional muscle disorder and the structural muscle injuries are the two group inside which can be classified the indirect muscle injuries (Reviewed by Mueller-Wohlfahrt et al. [20]). Recent studies have identified some genetic markers that could influence the predisposition to injuries in football [14–19]. However, to date, no study has looked at the MCT1rs1049434 variant.

Given the potential role of MCT1 in muscle soreness and injuries, the aim of the present study was to analyze the effect of the MCT1rs1049434 polymorphism on indirect muscle injury rates in top-level football players, during five competitive seasons. We hypothesized that the presence of the T allele (previously associated with greater arterial blood lactate levels) could be protective in developing pathogenesis of indirect muscle injuries due to the decreased transport mediated by MCT1 proteins from arterial blood into the muscle fibers for its oxidation.

Methods

Participants

One hundred seventy-three male elite football players (age 19.4 ± 5.2 years; height 177.1 ± 7.4 cm; weight 69.3 ± 8.8 kg) participated in the study. All participants have played at the Official National Football Championship (Serie A, Primavera, Allievi and Giovanissimi) during five seasons (2009–2014). Participants were all Italian (Caucasian) for ≥3 generations. The participants trained for ~8 weeks (25.0 ± 10.3 h per week) in the pre-season period and ~38 weeks during the competitive season (10.0 ± 7.4 h per week). Players who join/left the cohort were included/excluded from the date when they join/left the team. All participants provided informed written consent, and the study protocol was approved by the Ethics Committee of the club and it was in accordance with Declaration of Helsinki for Human Research of 1974 (last modified in 2000).

Study Design

The study design followed the consensus on definitions and data collection procedures in studies of football injuries outlined in the consensus document [21] and by UEFA [22].

Injuries Data Collection

Data was collected from 25 players (14.4 %) during the 2009–2010 season, 15 players (8.6 %) during the 2009–2011 season, 14 players (8.0 %) during the 2009–2013 season, 67 players (38.7 %) during the 2012–2013 season, and 53 players (30.6 %) during 2013–2014 season. The follow-up time for injuries was between 1 and 5 years. Injury data of players who left the team during the season, for example, due to a moving to another team, were included only for the period they were part of the roster. Players with an existing injury were not excluded from the study; however, their existing injuries were recorded and were not included in the study.

An indirect muscle injury was defined as any physical complaint occurring during practice that prevented a player from participating in training or match play for at least 1 day after the day of the onset [21]. Injuries were categorized under four degrees of severity based on the number of days’ absence: minimal (code 1; 1–3 days), mild (code 2; 4–7 days), moderate (code 3; 8–28 days), and severe (code 4; >28 days) [21]. The registration of a muscle injury was based on a clinical examination by the team medical staff. Time loss due to injury was recorded on a weekly basis by the team’s medical staff (physicians and coaches) using a standardized injury report form during the preseason and during the regular season.

Ultrasound and magnetic resonance imaging scans were used to morphologically classify the injuries. Muscle injuries included in the study were classified according to a scheme devised by Muller-Wohlfarth [20] derived from a recent consensus statement on sports injuries in relation to indirect mechanisms of injury (Table 1).

Table 1 Classification of indirect muscle disorders and injuries
Full size table

Participants with direct muscle injury (contusion and laceration) were excluded from the study.

Injury incidence was calculated per 1000 h of training exposure ((∑ number of muscle injuries/∑ h training exposure)×1000). Training exposure was defined as any team-based or individual physical activity, conducted under the control or guidance of the team’s coaching and fitness staff that was aimed at maintaining or improving players’ football skills or physical condition. Matches between teams were considered to be training exposure. Any match activity that was part of a player’s rehabilitation from injury was not recorded as a match exposure. The follow-up time was accounted in the injury incident calculation.

DNA Analysis

Genomic DNA was extracted from buccal swab using a QIAamp DNA Minikit (QIAGEN, Hilden, Germany). Concentration of extracted DNA was determined by fluorometric method (through Qubit by Invitrogen). On average, the DNA concentration registered was 20 μg/ml, which is sufficient for performing PCR.

Following performing the PCR, an electrophoresis on agarose gel was carried out as quality control to verify the purity of the PCR products. Genomic DNA from the subjects was analyzed by polymerase chain reaction (PCR) following the protocol previously published [9]. The primers used for amplification were as follows [8]: sense primer 5′-ACACATACTGGGCATGTGGC-3′ (1455–1474); antisense primer 5′-AAA TCCCATCAA TGA ACAACTGGTATGATTTCCAC-3′ (1807–1841). Using the primers and the missense polymorphism (rs1049434) described by Cupeiro et al. [9], we searched the sequence on gene bank. Through the Neb Cutter tool (http://tools.neb.com/NEBcutter2/index.php), we individuated the restriction enzyme BccI that allows to discriminate the presence or absence of missense polymorphism A1470T. This enzyme recognizes the sequence 3′-GGTAG-5′ and produces three fragments in the mutate sequence (TT: 14,171, and 202 bp), whilst only two fragments (AA: 14 and 373 bp) are generated in the wild sequence. Heterozigotes AT were individuated by four fragments: 14, 171, 202, and 373 bp.

Statistical Analysis

Levene’s tests were performed to verify the homogeneity of variances. ANOVA was used to examine the differences between genotype (or allele) groups and continuous data. Where appropriate, a Fisher LSD post hoc analysis was used to determine which of the three genotypes were significantly different from each other.

Hardy-Weinberg equilibrium was calculated using Genepop version 4.0.10 (http://genepop.curtin.edu.au). The P value for significance was set at P < 0.05.

Results

The estimated total incidence was 1.25 ± 3.0 muscles injuries per 1000 h of exposure. A total of 107 injuries recorded during the five seasons accounted for a loss of 2391 days, that is, absence from training in the pre-season and regular competitive season. The mean lay-off time for indirect muscle injuries amounted to 13.6 days.

Injuries were most likely to be in the lower extremities (thigh 82.2 %; leg 12.1 %). Muscle injuries in the lower extremities involved the biceps femoris (26.4 %), the rectus femoris (22.9 %), the gastrocnemius (11.4 %), the adductor magnus (11.4 %), the adductor longus (8.0 %), the ileopsoas (5.7 %), the semitendinosus (3.4 %), the semimembranosus (2.2 %), the adductor brevis (2.2 %), the popliteus (1.1 %), the sartorius (1.1 %), the soleus (1.1 %), the vastusmedialis (1.1 %), and the vastusintermedius (1.1 %). Table 2 reports the MCT1 genotype distribution based on the severity of muscle injuries resulting in absence from training sessions or matches.

Table 2 MCT1 genotype distribution based on the severity of muscle injuries resulting in absence from training sessions or matches
Full size table

Table 3 reports the number and percentage of muscle injuries classified according to the Munich Consensus Statement.

Table 3 Muscle injury classification according to the Munich consensus statement
Full size table

The MCT1rs1049434 genotype distribution (39.8 % AA, n = 69; 47.3 % AT, n = 82; 12.7 % TT, n = 22) was in Hardy-Weinberg equilibrium (P = 0.486) confirming no genotyping errors, population subdivision, viability selection, or systematic mating. Age (P = 0.322), height (P = 0.366), and weight (P = 0.353) were not significantly differentiated between the three genotype groups as well as the number of seasons played by the football players (P = 0.060) (Table 4).

Table 4 General characteristics of the football players when divided into the three MCT1 rs1049434 genotype (AA, AT, TT) groups
Full size table

Regarding the muscle injury variables, significant differences were found between MCT1 genotypes and incidence of muscle injuries (P = .048). In detail, football players with the TT genotype had lower incidence of muscle injuries compared to AA genotype carriers (AA = 1.57 ± 3.07, n = 69; TT = 0.09 ± 1.25; P = .044). No significant difference was found between genotypes and the severity of injuries (P > 0.05). Moreover, there was no correlation between the number of the recovery days and the SNP.

Finally, no significant difference between injuries from muscles that are primarily slow twitch compared to muscles that are primarily fast twitch was observed. In fact, the most injured muscles were the biceps femoris and rectus femoris that are primarily slow twitch and fast twitch, respectively.

Discussion

The main finding of the present study was that the MCT1 rs1049434 AA genotype is associated with higher incidence of injuries in elite football players. The mean incidence of indirect muscle injuries shown in the present study is in line with the recent published data (1.48; range 1.42 to 1.55) [23] on epidemiological and clinical muscle injuries in male elite football players (UEFA Elite League study of 2287 thigh injuries (2001–2013)).

Lactic acid is mainly dissociated into La− anions and protons (H+) at physiological pH status. During exercise and muscle contractions, muscle and blood anions (La−) and protons (H+) are typically raising up, depending on the exercise intensity [24, 25]. Lactic acid transport across the plasma membrane is fundamental for the metabolism and pH regulation of all cells, removing lactic acid produced by glycolysis and allowing uptake by those cells utilizing it for gluconeogenesis (liver and kidney) or as a respiratory fuel (heart and red muscle). Previous researches have argued that any detrimental effects of lactic acid on muscle and exercise performance are due to H+ rather than La− [26], even if other evidences have given alternative explanations of the biochemistry of metabolic acidosis [27]. Muscles predominantly composed of oxidative fibers (e.g., soleus) express considerable amounts of MCT1 and very little MCT4 [28, 29], whereas muscles with a large proportion of fast twitch, glycolytic fibers (e.g., white gastrocnemius) express primarily MCT4 and very little MCT1, which have different kinetic properties [29]. Both MCT1 and MCT4 participate in the cell–cell lactate shuttle, whereas MCT1 facilitates operation of the intracellular lactate shuttle [30].

Cupeiro et al. [9] have shown an association between the MCT1 rs1049434 polymorphism and lactate accumulation; higher capillary lactate accumulation was noted in men carrying the T allele during high-intensity circuit training. More recently, Cupeiro et al. [10] published another study in which they found a higher lactate accumulation in AA males, which would reflect a higher release of this molecule from the active fiber to the blood. Nevertheless, with the data available, the authors cannot conclude if the differences found between the two studies are due to the different blood type analyzed (capillary vs. venous), different training protocols used, or different muscle fiber proportions within each individual [31].

On the bases of the accepted “cell-to-cell lactate shuttle” model, the lactate movement across the sarcolemma during exercise is mediated by monocarboxylate transporters MCT1and MCT4 that are primarily responsible for lactate uptake from the circulation and lactate extrusion out of muscle, respectively [32]. Therefore, if we consider our results within this model, we could hypothesize that the highest incidence of muscle injuries displayed by football players with AA genotype could be due to acidic intracellular environment created by muscle activity due to the elevated lactate transport from arterial blood into the muscle fibers for its oxidation, as noted in the Cupeiro at al. study [10].

The possible link between muscle injuries and lactate level could be sought in the variations in lactate transporter that results in an acidic intracellular environment created by muscle activity with consequent degeneration of muscle and release of myoglobin and creatine kinase [33–35]. This factor might compromise extreme performance in healthy individuals. Considering that muscle fatigue has been shown to predispose to injury [11], lactate transporter variations in skeletal muscle might provide an explanation for some cases of muscle injuries due to the higher intramuscular lactate concentration, and genetic variations can explain some of the predisposition to injuries.

The primary limiting factor in genetic association studies is the need to recruit large groups of cases (elite athletes in this case) to overcome the obvious barrier of large sample size for detecting genetic associations. In regard to that, we stress that our sample is extremely homogeneous in terms of the level of the players (all elite-level football players), geographical origin of the participants (all Italians and Caucasians), sex (all males), and team (all from the same team). Hence, their exposure to training loads and injuries and other confounding variables are well controlled.

A specific limitation in the present study is lack of data on intramuscular lactate concentration that could, potentially, assist clarifying the physiological mechanism behind the genotype:phenotype association. Although our study may pave the way in looking at this specific SNP as potential genetic marker, more muscle-related injury and replication studies in larger cohorts as well as studies with more injury-related phenotypes are required to confirm this association.

Conclusions

In conclusion, we found that the MCT1 rs1049434 polymorphism is associated with the incidence of muscle injuries in elite football players. Additional research is required to support our data and to fully elucidate the relationship between predisposition to muscle injuries in football and the MCT1 rs1049434 polymorphism.

References

  1. 1.

    Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;343:281–99.

  2. 2.

    Bonen A. The expression of lactate transporters (MCT1and MCT4) in heart and muscle. Eur J Appl Physiol. 2001;86(1):6–11.

  3. 3.

    Hertz L, an Dienel GA. Lactate transport and transporters: general principles and functional roles in brain cells. J Neurosci Res. 2005;79(1–2):11–8.

  4. 4.

    Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol. 1993;264(4 Pt 1):C761–82.

  5. 5.

    Garcia CK, Li X, Luna J, Francke U. cDNA cloning of the human monocarboxylate transporter 1 and chromosomal localisation of the SLC16A1 locus to 1p13.2-p12. Genomics. 1994;15(23):500–3.

  6. 6.

    Bergersen LH. Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle. Neuroscience. 2007;145(1):11–9.

  7. 7.

    Juel C, Halestrap AP. Lactate transport in skeletal muscle role and regulation of the monocarboxylate transporter. J Physiol. 1999;517(Pt3):633–42.

  8. 8.

    Merezhinskaya N, Fishbein WN, Davis JI, Foellmer JW. Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve. 2000;23(1):90–7.

  9. 9.

    Cupeiro R, Benito PJ, Maffulli N, Calderón FJ, González-Lamuño D. MCT1 genetic polymorphism influence in high intensity circuit training: a pilot study. J Sci Med Sport. 2010;13(5):526–30.

  10. 10.

    Cupeiro R, González-Lamuño D, Amigo T, Peinado AB, Ruiz JR, Ortega FB, et al. Influence of the MCT1-T1470A polymorphism (rs1049434) on blood lactate accumulation during different circuit weight trainings in men and women. J Sci Med Sport. 2012;15(6):541–7.

  11. 11.

    Opar DA, Williams MD, Shield AJ. Hamstring strain injuries: factors that lead to injury and re-injury. Sports Med. 2012;42(3):209–26.

  12. 12.

    Ekstrand J, Gillquist J. Soccer injuries and their mechanisms: a prospective study. Med Sci Sports Exerc. 1983;15(3):267–70.

  13. 13.

    Inklaar H. Soccer injuries, I: incidence and severity. Sports Med. 1994;18(1):55–73.

  14. 14.

    Ficek K, Cieszczyk P, Kaczmarczyk M, Maciejewska-Karłowska A, Sawczuk M, Cholewinski J, et al. Gene variants within the COL1A1 gene are associated with reduced anterior cruciate ligament injury in professional soccer players. J Sci Med Sport. 2013;16:396–400.

  15. 15.

    Massidda M, Corrias L, Bachis V, Culigioni C, Piras F, Scorcu M, et al. Genetic polymorphisms and muscle injuries among Italian Soccer Players. Ann Sports Med Res. 2014;1:1004.

  16. 16.

    Massidda M, Bachis V, Corrias L, Piras F, Scorcu M, Calò CM. Influence of the COL5A1 rs12722 on musculoskeletal injuries in professional soccer players. J Sports Med Phys Fitness. 2015 Jan 13. [Epub ahead of print]

  17. 17.

    Massidda M, Corrias L, Bachis V, Cugia P, Piras F, Scorcu M, et al. VDR polymorphisms and musculotendinous injuries in professional football players. Exp Ther Med. 2015;9:1974–8.

  18. 18.

    Pruna R, Artells R, Ribas J, Montoro B, Cos F, Muñoz C, et al. Single nucleotide polymorphisms associated with non-contact soft tissue injuries in elite professional soccer players: influence on degree of injury and recovery time. BMC Musculoskelet Disord. 2013;14:221.

  19. 19.

    Pruna R, Ribas J, Montoro JB, Artells R. The impact of single nucleotide polymorphisms on patterns of non-contact musculoskeletal soft tissue injuries in a football player population according to ethnicity. Med Clin (Barc). 2015;144(3):105–10.

  20. 20.

    Mueller-Wohlfahrt HW, Haensel L, Mithoefer K, Ekstrand J, English B, McNally S, et al. Terminology and classification of muscle injuries in sport: a consensus statement. Br J Sports Med. 2013;47(6):342–50.

  21. 21.

    Fuller CW, Ekstrand J, Junge A, Andersen TE, Bahr R, Dvorak J, et al. Consensus statement on injury definitions and data collection procedures in studies of football (soccer) injuries. Br J Sports Med. 2006;40(3):193–201.

  22. 22.

    Hägglund M, Waldén M, Bahr R, Ekstrand J. Methods for epidemiological study of injuries to professional football players: developing the UEFA model. Br J Sports Med. 2005;39(6):340–6.

  23. 23.

    Ueblacker P, Mueller-Wohlfahrt HW, Ekstrand J. Epidemiological and clinical outcome comparison of indirect (‘strain’) versus direct (‘contusion’) anterior and posterior thigh muscle injuries in male elite football players: UEFA Elite League study of 2287 thigh injuries (2001–2013). Br J Sports Med. 2015 Mar 9. pii: bjsports-2014-094285. doi: 10.1136/bjsports-2014-094285. [Epub ahead of print].

  24. 24.

    Sahlin K, Harris RC, Nylind B, Hultman E. Lactate content and pH in muscle obtained after dynamic exercise. Pflugers Arch. 1976;367(2):143–9.

  25. 25.

    Fitts RH. Mechanisms of muscular fatigue. In: Poortmans JR, editor. Principles of exercise biochemistry. 3rd ed. Basel: Karger; 2003. p. 279–300.

  26. 26.

    Pilegaard H, Terzis G, Halestrap A, Juel C. et al. Distribution of the lactate/H+ transporter isoforms MCT1 and MCT4 in human skeletal muscle. Am J Physiol. 1999;276(5 Pt 1):E843–8.

  27. 27.

    Juel C, Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J PhysiolRegulIntegr Comp Physiol. 2004;287(3):R502–16.

  28. 28.

    Fishbein WN, Merezhinskaya N, Foellmer JW. Relative distribution of three major lactate transporters in frozen human tissues and their localization in unfixed skeletal muscle. Muscle Nerve. 2002;26(1):101–12.

  29. 29.

    Dubouchaud H, Butterfield GE, Wolfel EE, Bergman BC, Brooks GA. Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle. Am J Physiol Endocrinol Metab. 2000;278(4):E571–9.

  30. 30.

    Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 2004;558(Pt 1):5–30.

  31. 31.

    Merezhinskaya N, Fishbein WN. Monocarboxylate transporters: past, present, future. Histol Histopathol. 2009;24(2):243–64.

  32. 32.

    Huang Y, Xiao T, Liang Y. Progress in study of exercise, monocarboxylate transporter 1 and lactic shuttle. Life Science J. 2007;4(3):57–63.

  33. 33.

    Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 2000;19(15):3896–904.

  34. 34.

    Cuff MA, Lambert DW, Shirazi-Beechey SP. Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J Physiol. 2002;539(Pt 2):361–71.

  35. 35.

    Sepponen K, Koho N, Puolanne E, Ruusunen M, Pösö AR. Distribution of monocarboxylate transporter isoforms MCT1, MCT2 and MCT4 in porcine muscles. Acta Physiol Scand. 2003;177(1):79–86.

Download references

Author information

Affiliations

  1. Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy
    • Myosotis Massidda
    • , Valeria Bachis
    • , Laura Corrias
    • , Claudia Culigioni
    •  & Carla M. Calò
  2. Institute of Sport, Exercise and Active Living (ISEAL), Victoria University, Victoria, Australia
    • Nir Eynon
  3. FIMSI CR Sardegna and Cagliari Calcio Spa, Cagliari, Italy
    • Francesco Piras
    • , Paolo Cugia
    •  & Marco Scorcu
Authors
  1. Myosotis Massidda
    View author publications
    You can also search for this author in
  2. Nir Eynon
    View author publications
    You can also search for this author in
  3. Valeria Bachis
    View author publications
    You can also search for this author in
  4. Laura Corrias
    View author publications
    You can also search for this author in
  5. Claudia Culigioni
    View author publications
    You can also search for this author in
  6. Francesco Piras
    View author publications
    You can also search for this author in
  7. Paolo Cugia
    View author publications
    You can also search for this author in
  8. Marco Scorcu
    View author publications
    You can also search for this author in
  9. Carla M. Calò
    View author publications
    You can also search for this author in

Corresponding author

Correspondence to Myosotis Massidda.

Additional information

Competing interests

Myosotis Massidda, Nir Eynon, Valeria Bachis, Laura Corrias, Claudia Culigioni, Francesco Piras, Paolo Cugia, Marco Scorcu, Carla M.Calò declare that they have no conflict of interest. No financial support was received for the conduct of this study or preparation of this manuscript.

Authors' contributions

CC participated in DNA collection and carried out the genotyping. CMC partecipated in writing and reviewing the article. FP partecipated in injuries data collection. LC partecipated in genotyping and DNA collection. MM designed the research, carried out the DNA collection, analyzed the data and wrote the article. MS carried out the injuries data collection. NE partecipated in writing and reviewing the article. PC partecipated in injuries data collection. VB partecipated in DNA collection and genotyping. All authors read and approved the final manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Massidda, M., Eynon, N., Bachis, V. et al. Influence of the MCT1 rs1049434 on Indirect Muscle Disorders/Injuries in Elite Football Players. Sports Med - Open 1, 33 (2015). https://doi.org/10.1186/s40798-015-0033-9

Download citation

Keywords

  • Elite athletes
  • Football
  • Genetic association
  • Lactate
  • Muscle injuries
  • Monocarboxylate transporter-1